Patient- and Practice-Centered Assessment of Self-Collection
以患者和实践为中心的自取评估
基本信息
- 批准号:8729296
- 负责人:
- 金额:$ 29.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AddressAmerican IndiansAppalachian RegionCaringCervicalCervical Cancer ScreeningClinicClinicalClinical SensitivityCollectionCommunitiesCommunity PracticeComplexContinuity of Patient CareCounselingCountryCytologyDNADecision MakingDevelopmentDiseaseDocumentationEffectivenessEvaluationFailureHispanicsHome environmentHuman PapillomavirusIncomeInterventionIntervention TrialInterviewLifeLinkMalignant NeoplasmsMalignant neoplasm of cervix uteriMethodsMexicoMississippiNew MexicoOutcomeOutcome MeasurePatient CarePatientsPerformancePhasePopulationPovertyPrevention programPrimary Health CareProcessProviderResourcesSample SizeSamplingSelf AssessmentSpecimenTest ResultTestingTranslational ResearchUnderserved PopulationWomanWorkagedbasecancer carecervical cancer preventioncervicovaginaldesignexperienceinnovationmedically underservednovel strategiespatient populationprimary care settingprogramsscreeningtranslational studywillingness
项目摘要
Failures to screen women for cervical cancer are well documented. The current U.S. screening program
fails to reach small pockets of populations living mainly in low-resource, medically underserved regions as
part of a complex of diseases linked to poverty and/or racial disparities. These populations have cen/ical
cancer rates that are similar to middle-income countries and contribute approximately 60% of the cervical
cancer cases that occur annually in the U.S. it is reasonable to suggest that the current cervical cancer
prevention program has reached its limits and innovative strategies are needed to overcome these
barriers and further reduce the burden in underserved populations. HPV DNA testing offers a promising
strategy to enhance cervical screening coverage and address both patient and primary care provider
challenges along the care process. HPV DNA testing is highly sensitive (90-95%) for identifying women
with cervical precancer and cancer when using a clinician-collected specimen, and 20-50% more sensitive
than routine cytology programs. Thus, self-collection combined with HPV DNA testing can potentially be
used to extend access to women who are not reached by current Pap-based programs. However, there
are only limited, small studies of self-collection in the U.S. and more work is needed to determine whether
self-collection is acceptable to diverse patient populations as well as potential barriers toward integration
of this approach into primary care settings. This mixed method study is designed to:
1. fully describe the current cervical cancer screening and treatment care continuum, and to assess the
translational potential of a promising new approach - self-collection - by conducting a three-phase
sequential mixed-method translational study (Phase la):
2. involve American Indian and Hispanic women in the co-development of a culturally-appropriate
approach to self-collection (Phase lb):
3. integrate practice assessment and patient findings (Aims 1 and 2) in an intervention to assess the
feasibility and comparability of self-collection methods for HPV testing and routine cervical cytology with
HPV co-testing in four purposefully selected primary care clinical settings: (Phase 2)
没有对妇女进行宫颈癌筛查是有充分记录的。目前美国的筛查项目
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Andrew Louis Sussman其他文献
Andrew Louis Sussman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Andrew Louis Sussman', 18)}}的其他基金
Women in Survivorship Healthcare (WISH): Implementation of a Nurse Navigation Model for Medically Underserved Breast and Gynecologic Cancer Survivors using Project ECHO
女性幸存者医疗保健 (WISH):使用 ECHO 项目为医疗服务不足的乳腺癌和妇科癌症幸存者实施护士导航模型
- 批准号:
10021610 - 财政年份:2019
- 资助金额:
$ 29.77万 - 项目类别:
Patient- and Practice-Centered Assessment of Self-Collection
以患者和实践为中心的自取评估
- 批准号:
8555412 - 财政年份:2011
- 资助金额:
$ 29.77万 - 项目类别:
Participatory Research to Understand the Translation of HPV Vaccine Policy
了解 HPV 疫苗政策转化的参与式研究
- 批准号:
7497826 - 财政年份:2008
- 资助金额:
$ 29.77万 - 项目类别:
Participatory Research to Understand the Translation of HPV Vaccine Policy
了解 HPV 疫苗政策转化的参与式研究
- 批准号:
7690200 - 财政年份:2008
- 资助金额:
$ 29.77万 - 项目类别:
Patient- and Practice-Centered Assessment of Self-Collection
以患者和实践为中心的自取评估
- 批准号:
8566819 - 财政年份:
- 资助金额:
$ 29.77万 - 项目类别:
相似海外基金
Communication in American Indians thru Strategies for Equity 4 Cancer (CASE4Cancer)
美国印第安人通过公平策略进行沟通 4 癌症 (CASE4Cancer)
- 批准号:
10892489 - 财政年份:2023
- 资助金额:
$ 29.77万 - 项目类别:
Digital smoking cessation intervention for nationally-recruited American Indians and Alaska Natives: A full-scale randomized controlled trial
针对全国招募的美洲印第安人和阿拉斯加原住民的数字戒烟干预:一项全面的随机对照试验
- 批准号:
10826067 - 财政年份:2023
- 资助金额:
$ 29.77万 - 项目类别:
Medication Adherence and Cardio-Metabolic Control Indicators among Adult American Indians Receiving Tribal Health Services
接受部落卫生服务的成年美洲印第安人的药物依从性和心脏代谢控制指标
- 批准号:
10419967 - 财政年份:2022
- 资助金额:
$ 29.77万 - 项目类别:
Examination of evolving opioid misuse and overdose risk among American Indians
检查美洲印第安人中不断变化的阿片类药物滥用和过量风险
- 批准号:
10438466 - 财政年份:2022
- 资助金额:
$ 29.77万 - 项目类别:
Examination of evolving opioid misuse and overdose risk among American Indians
检查美洲印第安人中不断变化的阿片类药物滥用和过量风险
- 批准号:
10701719 - 财政年份:2022
- 资助金额:
$ 29.77万 - 项目类别:
Culturally Responsive Palliative Care Messaging for American Indians: An Efficacy Trial
针对美洲印第安人的文化响应姑息治疗信息:功效试验
- 批准号:
10431092 - 财政年份:2022
- 资助金额:
$ 29.77万 - 项目类别:
Culturally Responsive Palliative Care Messaging for American Indians: An Efficacy Trial
针对美洲印第安人的文化响应姑息治疗信息:功效试验
- 批准号:
10709495 - 财政年份:2022
- 资助金额:
$ 29.77万 - 项目类别:
Advancing Palliative Care in Northern Plains American Indians
推进北部平原美洲印第安人的姑息治疗
- 批准号:
10705232 - 财政年份:2022
- 资助金额:
$ 29.77万 - 项目类别:
Long-term consequences of SARS-CoV-2 infection and COVID-19 disease among American Indians: an ambidirectional cohort study in the Cherokee Nation
美洲印第安人中 SARS-CoV-2 感染和 COVID-19 疾病的长期后果:切罗基族的双向队列研究
- 批准号:
10438443 - 财政年份:2022
- 资助金额:
$ 29.77万 - 项目类别:
Advancing Palliative Care in Northern Plains American Indians
推进北部平原美洲印第安人的姑息治疗
- 批准号:
10643600 - 财政年份:2022
- 资助金额:
$ 29.77万 - 项目类别: